Rodrigues M - Search Results

1

[Homologous recombination deficiency and PARP inhibitors in therapeutics].

Salaün H, Saint-Ghislain M, Bellesoeur A, Beuzeboc P, Neuzillet C, Diéras V, Stern MH, Rodrigues M. Salaün H, et al. Among authors: rodrigues m. Bull Cancer. 2022 Jan;109(1):76-82. doi: 10.1016/j.bulcan.2021.09.015. Epub 2021 Nov 17. Bull Cancer. 2022. PMID: 34799081 Review. French.

2

Time to metastatic relapse and breast cancer cells dissemination in bone marrow at metastatic relapse.

Bidard FC, Vincent-Salomon A, Sigal-Zafrani B, Rodrigues M, Diéras V, Mignot L, Sastre-Garau X, Poupon MF, Pierga JY. Bidard FC, et al. Among authors: rodrigues m. Clin Exp Metastasis. 2008;25(8):871-5. doi: 10.1007/s10585-008-9203-1. Epub 2008 Nov 7. Clin Exp Metastasis. 2008. PMID: 18989740

3

[Role of high-throughput sequencing in oncology].

Rodrigues MJ, Gomez-Roca C. Rodrigues MJ, et al. Bull Cancer. 2013 Mar;100(3):295-301. doi: 10.1684/bdc.2013.1717. Bull Cancer. 2013. PMID: 23501647 Review. French.

4

[Targeted therapy in locally and metastatic recurrent cervical cancers].

Geiss R, De La Motte Rouge T, Dubot C, Leary A, Lhommé C, Pautier P, Scholl S, Rodrigues MJ. Geiss R, et al. Bull Cancer. 2014 Jul-Aug;101(7-8):748-55. doi: 10.1684/bdc.2014.1949. Bull Cancer. 2014. PMID: 25091657 Review. French.

5

[The quest for immunotherapy response biomarkers still goes on].

Rodrigues MJ. Rodrigues MJ. Bull Cancer. 2016 Oct;103(10):813-814. doi: 10.1016/j.bulcan.2016.08.003. Epub 2016 Sep 20. Bull Cancer. 2016. PMID: 27663101 French. No abstract available.

6

[Hot topics in 2017 in oncology and hematology. A selection by the editorial board of Bulletin du Cancer].

Vignot S, André T, Caux C, Bouleuc C, Evrard S, Gonçalves A, Lacroix M, Magné N, Massard C, Mazeron JJ, Orbach D, Rodrigues M, Thariat J, Wislez M, L'Allemain G, Bay JO. Vignot S, et al. Among authors: rodrigues m. Bull Cancer. 2018 Jan;105(1):6-14. doi: 10.1016/j.bulcan.2017.11.006. Bull Cancer. 2018. PMID: 29269176 Review. French.

7

[Can medical oncologists talk about cure to their patient after localized breast cancer treatment?].

Torregrosa C, Coutu-Nadeau LP, Rodrigues MJ, Mamzer-Bruneel MF. Torregrosa C, et al. Bull Cancer. 2018 Mar;105(3):222-227. doi: 10.1016/j.bulcan.2017.10.034. Bull Cancer. 2018. PMID: 29402398 French.

8

[The place of cancer's cure in the personalized medicine and immunotherapy].

Torregrosa C, Rodrigues M, Mamzer-Bruneel MF. Torregrosa C, et al. Among authors: rodrigues m. Bull Cancer. 2018 Mar;105(3):220-221. doi: 10.1016/j.bulcan.2017.11.013. Bull Cancer. 2018. PMID: 29422247 French. No abstract available.

9

[MBD4 inactivation induces a new mutator phenotype in cancers].

Rodrigues M, Mobuchon L, Houy A, Derrien AC, Stern MH. Rodrigues M, et al. Bull Cancer. 2018 Sep;105(9):736-737. doi: 10.1016/j.bulcan.2018.06.006. Epub 2018 Jul 19. Bull Cancer. 2018. PMID: 30032956 French. No abstract available.

10

[Editorial of the French Society of Cancer].

Rodrigues M; et l'ensemble des membres du Bureau de la Société Française du Cancer. Rodrigues M, et al. Bull Cancer. 2019 Jan;106(1):4. doi: 10.1016/j.bulcan.2019.01.003. Bull Cancer. 2019. PMID: 30709566 French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,453 results

Search Page